TY  - JOUR
TI  - Adverse effects of dopamine potentiation by long-term treatment with selegiline
SP  - 107
EP  - 109
A1  -  Hollán Zsuzsa
A1  -  Vécsei László
A1  -  Magyar Kálmán
SN  - 0885-3185
ID  - publicatio10113
AV  - restricted
JF  - MOVEMENT DISORDERS
IS  - 1
N2  - A patient with triosephosphate isomerase (TPI) deficiency exhibited worsening of abnormal involuntary movements of the dystonic type and developed psychiatric symptoms while on selegiline. When selegiline was stopped after 9 years of treatment, abnormal involuntary movements improved to pretreatment level and psychiatric behaviour returned to normal. Monoamine oxidase-B platelet activity was low in this patient. (C) 2003 Movement Disorder Society.
N1  - FELTÖLT?: Gyengéné Ruszka Marian - gyengeneruszka@freemail.hu
UR  - http://publicatio.bibl.u-szeged.hu/10113/
VL  - 19
Y1  - 2004///
ER  -